bannter.jpg

Citation: Noh HJ, Kim ST. Combined treatment of phacoemulsification and single-port limited pars plana vitrectomy in acute angle-closure glaucoma. Int J Ophthalmol 2019;12(6):974-979

DOI:10.18240/ijo.2019.06.15


·
Clinical Research·

 

Combined treatment of phacoemulsification and single-port limited pars plana vitrectomy in acute angle-closure glaucoma

 

Ha Jeong Noh, Seong Taeck Kim

 

Department of Ophthalmology, Chosun University Hospital, Dong-gu, Gwang-ju 501-717, Republic of Korea

Correspondence to: Seong Taeck Kim, Department of Ophthalmology, Chosun University Hospital, 365 Pilmundaero, Dong-gu, Gwang-ju 501-717, Republic of Korea. s20age@hanmail.net

Received: 2018-07-05        Accepted: 2019-02-25

 

Abstract

AIM: To evaluate the efficacy of combined treatment of phacoemulsification (PE) and micro-incisional single-port transconjunctival limited pars plana vitrectomy (PPV) in acute angle-closure glaucoma (AACG).

METHODS: A retrospective study included 26 patients who underwent PE diagnosed with AACG. Among them, 16 patients (16 eyes) underwent PE alone, 10 patients (10 eyes) underwent combined limited vitrectomy and PE. Then we compared intraocular pressure (IOP), anterior chamber angle, anterior chamber depth, central corneal thickness and corneal endothelial cell count before and after surgery, and effective PE time during cataract surgery.

RESULTS: Effective PE time was shorter in the combined surgery group than in the single surgery group (P=0.040). There was no statistically significant difference in IOP and best-corrected visual acuity between the two groups postoperatively. At 6mo postoperatively, there was no difference in the anterior chamber angle, anterior chamber depth, and central corneal thickness between two groups, but corneal endothelial cell count was higher in the combined surgery group than in the single surgery group (P=0.046). No complication such as vitreoretinal disease, endophthalmitis, bullous keratopathy was noted.

CONCLUSION: Combined micro-incisional single-port transconjunctival limited PPV and PE are more effective and safer than PE alone because of less operation time and fewer complications for management of AACG.

KEYWORDS: limited vitrectomy; phacoemulsification; acute angle-closure glaucoma

DOI:10.18240/ijo.2019.06.15

 

Citation: Noh HJ, Kim ST. Combined treatment of phacoemulsification and single-port limited pars plana vitrectomy in acute angle-closure glaucoma. Int J Ophthalmol 2019;12(6):974-979

 

INTRODUCTION

Acute angle-closure glaucoma (AACG) is caused by the relative pupillary block or a sudden closure of the anterior chamber angle, which result in a severe intraocular pressure (IOP) rise. Laser iridotomy is a safe and effective nonsurgical treatment to resolve the relative pupillary block and to widen the anterior chamber angle[1]. However, laser iridotomy is not always effective in controlling IOP, and in some cases it often fails to control IOP[2]. One of the causes of this result is that the lens pushes the peripheral iris forward, making the anterior chamber shallower[3]. Old patients with AACG are more likely to be associated with cataracts. In this case, phacoemulsification (PE) may result in the increase of the anterior chamber depth and the decrease of IOP. So, many studies have reported that cataract surgery in patients with AACG can lower IOP[4]. However, cataract surgery in patients with AACG has difficulties due to anatomical problems such as shallow anterior chamber, high IOP, small pupil, corneal edema, and weak zonule[5]. High-vitreous pressure in such eyes can result in capsulorhexis extension, iris prolapse, zonular dialysis or posterior capsular rupture with subsequent vitreous loss and possibly suprachoroidal haemorrhage[6]. Extreme caution is recommended when operating on eyes with shallow anterior chamber. Therefore, cataract surgery in patients with AACG results in prolonged PE ultrasound time and increased corneal endothelial damage[7-8].

If the vitreous pressure is lower before performing cataract surgery, the cataract surgery can be performed much easier and safer. In 2001, Chang[9] performed vitreous aspiration to lower the vitreous pressure using a 20-gauge vitrectomy cutter in PE for management of AACG. However, vitreous aspiration could be a good technique in vitrectomized eye, but could fail to aspirate the vitreous in non-vitrectomized eye. If vitreous was aspirated strongly, the risk of complications such as retinal detachment and vitreous hemorrhage were increased. In addition, vitreous aspiration was required a large sized needle and conjunctival peritomy was necessary to suture the sclerotomy, which may affect the poor outcome of glaucoma surgery in the future[10]. Currently, micro-incisional transconjunctival sutureless pars plana vitrectomy (PPV) is widely used in vitreoretinal surgery due to the development of the instrument. The performance of the PPV with a higher cutting rate and the smaller diameter of vitrectomy cutter has been improved so that the vitreous traction can be effectively reduced and the possibility of making on iatrogenic retinal tear can be reduced. Dada et al[11] in 2007 described a single-port-limited PPV without infusion cannula using a 23-gauge vitrectomy probe inserted through a sclerotomy incision 3.5 mm from the limbus in PE for management of phacomorphic glaucoma. Miura et al[12] in 2008 introduced a single-port-limited PPV using a 23-gauge vitrectomy cutter before performing PE for management of acute angle closure. In this study, we evaluate the effectiveness of combined limited PPV and PE compared with PE alone in patients with AACG.

SUBJECTS AND METHODS

Ethical Approval  The study protocol was approved by the institutional review board (IRB) of the Chosun University Hospital and followed the Declaration of Helsinki. All participants signed an informed consent. And all participants didn’t receive a stipend.

Study Design  We retrospectively reviewed the medical records of 26 patients who underwent PE to manage AACG from March 2011 to October 2016. Of these, 16 patients (16 eyes)  underwent PE alone, and 10 patients (10 eyes) underwent combined pars plana vitrectomy and phacoemulsification (PPV+PE). Secondary glaucoma, such as neovascular glaucoma and uveitic glaucoma, was excluded from the study. Patients with corneal disease and vitreoretinal disease that may affect visual acuity were also excluded.

Surgical Technique  In patients with AACG, to lower IOP, we performed laser iridotomy. We performed cataract surgery emergently in AACG patients who have difficulty performing laser iridotomy due to severe corneal edema, and can’t lower IOP after laser iridotomy and medication. Surgery was performed by one surgeon (Kim ST) who had been adopting the use of this technique for several years. Retrobulbar local anaesthetic mixture of lidocaine 1% and bupivacaine 0.5% was injected. In combined surgery group, limited PPV was performed prior to the PE to lower posterior vitreous pressure. Patient selection for PE alone or combined surgery is conducted randomly selection without specific criteria. A 25-gauge trocar was inserted at a distance of 3.5 mm from the corneal limbus. A 25-gauge vitrectomy cutter was placed at the center of the eyeball and a limited PPV was performed with 5000 cuts/min and 100 mm Hg vacuum. When the eyeball was softened by digital IOP check, the vitrectomy cutter was removed and then the trocar was removed. If leakage was not seen, suturing was not performed. And, PE was performed. Ultrasound energy and total PE time were recorded to calculate effective phacoemulsification time (EPT). The EPT during cataract surgery recorded the cumulative dissipated energy (CDE) value of Infinity® (Alcon Laboratories Inc.). Intraoperative complications were recorded.

Retrospective Chart Review  Preoperative and demographic data were retrieved. Preoperative and postoperative best-corrected visual acuity, IOP, and complications were reviewed. Recorded preoperative and postoperative Snellen best-corrected visual acuity was converted to logarithmic minimal angle of resolution (logMAR) units for statistical analysis. Preoperative axial length had been measured by IOL Master® (Carl Zeiss Meditec, Dublin, CA, USA). Preoperative and postoperative anterior chamber depth, and central corneal thickness had been measured by Visante OCT® (Carl Zeiss Meditec Inc., Dublin, CA, USA). Anterior chamber angle, anterior chamber depth, central corneal thickness and corneal endothelial cell count were measured at 6mo postoperatively. Postoperative corneal endothelial cell counts were measured by non-contact specular microscope (SP-2000P®, Topcon, Tokyo, Japan). It was difficult to measure the preoperative corneal endothelial cell counts due to corneal edema. Intraoperative data such as EPT and intraoperative complications, if any, were collected. Postoperative complications such as corneal edema, hyphema, and posterior capsular rupture were also reviewed.

Statistical Analysis  Statistical analysis was performed using SPSS 21.0 for windows (version 17.0 SPSS Inc., Chicago, IL, USA). Means±standard deviations (SD) were used for descriptive data. Statistical evaluation was based on an independent samples t-test, Mann-Whitney U-test and Pearson’s Chi-square test. P<0.05 was considered significant.


RESULTS

The mean age of the patients was 68.69±7.46y in the PE single surgery group, and 67.70±9.42y in the PPV+PE combined surgery group (P=0.769). The mean preoperative IOP was 52.56±7.14 mm Hg in the PE, 51.40±9.56 mm Hg in the PPV+PE (P=0.726), and the best corrected visual acuity (logMAR) was 1.78±0.44 in the PE and 1.67±0.41 in the PPV+PE (P=0.604). There was no difference in axial length, anterior chamber depth, and central corneal thickness between the two groups preoperatively (P=0.725, 0.339, 0.425 respectively; Table 1). The mean effective PE time was 21.88±6.93s in the PE and 16.20±5.67s in the PPV+PE. PPV+PE was statistically significantly shorter than PE (P=0.040; Figure 1). Postoperative IOP was 11.06±2.11, 11.13±1.71, 12.44±1.75, 11.94±2.02, and 12.12±2.23 mm Hg at 1d, 1wk, 1, 3, and 6mo in the PE, 10.80±1.32, 12.01±2.16, 11.70±1.89, 12.40±1.71  and 13.30±1.70 mm Hg at 1d, 1wk, 1, 3, and 6mo in the PPV+PE. The difference in IOP between the two groups was not statistically significant (P=0.729, P=0.262, P=0.320, P=0.553, P=0.319; Figure 2). There was no case who need anti-glaucoma medication or glaucoma surgery postoperatively. Postoperative best-corrected visual acuity (logMAR) was 0.95±0.45, 0.59±0.35, 0.23±0.12, 0.21±0.13, and 0.23±0.16 at 1d, 1wk, 1, 3, and 6mo in the PE, 0.78±0.32, 0.45±0.29, 0.24±0.15, 0.17±0.16, and 0.19±0.14 at 1d, 1wk, 1, 3 and 6mo in the PPV+PE. The difference in postoperative best-corrected visual acuity between the two groups was not statistically significant (P=0.222, P=0.311, P=0.784, P=0.472, P=0.581; Figure 3). At 6mo postoperatively, the anterior chamber angle, anterior chamber depth, and central corneal thickness were not different statistically between the two groups (P=0.689, P=0.143, P=0.697), but corneal endothelial cell count was higher in the PPV+PE than in the PE statistically (P=0.046; Table 2). There were a few intraoperative complications, 4 cases of iris injury, 2 cases of anterior capsular tear, 2 cases of posterior capsular rupture in the PE, and 1 case of iris injury and 1 case of anterior capsular tear, no case of posterior capsular rupture in the PPV+PE. Postoperative complications were included corneal edema, cyclitic membrane and hyphema in both groups. In addition, complications such as retinal detachment, endophthalmitis, and bullous keratopathy did not occur (Table 3).

Table 1 Preoperative clinical characteristics               mean±SD

Parameters

PE (n=16)

PPV+PE (n=10)

P

Age (y)

68.69±7.46

67.70±9.42

0.769

Sex (M/F)

3/13

1/9

0.566

IOP (mm Hg)

52.56±7.14

51.40±9.56

0.726

BCVA (logMAR)

1.78±0.44

1.67±0.41

0.604

Axial length (mm)

22.16±0.70

22.26±0.73

0.725

ACD (mm)

2.17±0.24

2.07±0.30

0.339

CCT (μm)

611.50±61.71

628.70±31.76

0.425

IOP: Intraocular pressure; BCVA: Best corrected visual acuity; ACD: Anterior chamber depth; CCT: Central corneal thickness; PE: Phacoemulsification; PPV: Pars plana vitrectomy.

 

Ha Jeong Noh1

Figure 1 Effective phacoemulsification (PE) time between PE and combined pars plana vitrectomy and phacoemulsification (PPV+PE)  Effective PE time was shorter in the PPV+PE than in the PE (P=0.040).

Ha Jeong Noh2

Figure 2 Postoperative intraocular pressure between phacoemulsification (PE) and combined pars plana vitrectomy and phacoemulsification (PPV+PE)  There was no significant difference between two groups (by Mann-Whitney U-test).

Ha Jeong Noh3

Figure 3 Postoperative best-corrected visual acuity between phacoemulsification (PE) and combined pars plana vitrectomy and phacoemulsification (PPV+PE)  There was no significant difference between two groups (by Mann-Whitney U-test).

 

Table 2 Postoperative clinical characteristics         mean±SD

Parameters

PE (n=16)

PPV+PE (n=10)

P

ACA (degree)

18.50±4.41

17.80±4.05

0.689

ACD (mm)

3.08±0.36

3.27±0.41

0.143

CCT (μm)

516.56±16.90

513.60±21.20

0.697

ECC

1912.75±457.72

2317.70±510.29

0.046

ACA: Anterior chamber angle; ACD: Anterior chamber depth; CCT: Corneal central thickness; ECC: Corneal endothelial cell count; PE: Phacoemulsification; PPV: Pars plana vitrectomy.

Table 3 Complication                               n (%)

Complication

PE (n=16)

PPV+PE (n=10)

Intraoperative

 

 

Iris prolapse

4 (25)

1 (10)

Capsulorhexis extension

2 (12.5)

1 (10)

PC rupture

2 (12.5)

0

Zonulolysis

1 (6.25)

0

Dropped nuclear fragment

0

0

Postoperative

 

 

Corneal edema

12 (75)

5 (50)

Cyclitic membrane

6 (37.5)

3 (30)

Hyphema

2 (12.5)

1 (10)

Retinal detachment

0

0

Endophthalmitis

0

0

Bullous keratopathy

0

0

PC: Posterior capsule; PE: Phacoemulsification; PPV: Pars plana vitrectomy.

 

DISCUSSION

In the treatment of AACG, it is important to restore angle to prevent the peripheral anterior synechia[13]. Laser iridotomy is a treatment of choice for AACG. However, Aung et al[14] reported that long-term normal IOP range was maintained only in 41.8% of Asian eyes when laser iridotomy was performed for AACG. The reason why IOP may not well controlled after laser iridotomy is that the iris is thick and dark brown color in Asian. Therefore, when laser iridotomy is performed, there is a high possibility of closing the trabecular meshwork because of inflammatory response and dispersion of iris pigment. The second reason is that the lens becomes thicker with aging, which is likely to cause an angle-closure anatomically[15]. For this reason, there has been a report that it is possible to lower IOP by cataract surgery that can remove the factor of phacomorphic characteristic[16]. Jacobi et al[17] reported that high IOP was effectively controlled in 75% of patients with AACG by cataract surgery alone. It reported that 1.40±0.71 mm increase of anterior chamber depth, reduction of the IOP from 40.50±7.60 to 17.80±3.40 mm Hg, and 0.52±0.29 improvement of best-corrected visual acuity (logMAR) after cataract surgery. In our study, mean anterior chamber depth increased by 0.91±0.30 mm, mean IOP decreased from 52.56±7.14 to 12.12±2.23 mm Hg, and best-corrected visual acuity improved by 1.55±0.30 after cataract surgery. However, when cataract surgery is performed in patients with AACG, shallow anterior chamber interferes with almost every step, starting from the creation of wound incisions and capsulorhexis until the intraocular lens implantation. Working in a shallow anterior chamber increases the risks of Descemet’s membrane detachment, capsulorhexis extension, iris prolapse, and zonular dialysis[18]. In our study, we had intraoperative complications such as capsulorhexis extension, posterior capsular rupture and zonular dialysis.

Corneal endothelial cell loss is a main concern due to the closer distance between PE tip and corneal endothelium. In addition, during performing cataract surgery in AACG, the ultrasound PE time may be long, and the corneal endothelial cell damage increases[19-21]. Severe corneal endothelial damage can result in corneal edema, which can lead to permanent visual loss[22]. The normal corneal endothelial cell density is 2500 cells/mm2, and corneal edema and corneal decompensation can occur when the corneal endothelial cell density is reduced under 500 cells/mm2[23]. It is known that corneal endothelial cell density decreases from 0.89% to 1% per year even naturally, and the rate of decrease is about 2% per year after cataract surgery[24]. Factors affecting corneal endothelial cell damage in cataract surgery include patient-related factors such as age and severity of cataract, and operative factors such as surgeon factor, viscoelastic materials, ultrasound emulsification time, and ultrasound emulsification energy[25]. The lower the anterior chamber depth is, the higher damage of the corneal endothelial cell becomes. Igarashi et al[26] reported corneal endothelial damage by the surgical instrument, which is related to anterior chamber depth. Lee et al[27] reported the corneal endothelial cell density would be less than 1900 cells/mm2 in patients who underwent PE for the initial treatment of AACG.

Therefore, performing limited PPV to remove small volume of vitreous is considered the only possible way to successfully deepen the anterior chamber. This technique makes it easier to perform cataract surgery and reduce the incidence of complications. In addition, the risk of corneal endothelial cell damage can be reduced. In comparison with that, in our study, corneal endothelial cell density in the single surgery group was 1912 cells/mm2 at postoperative 6mo, corneal endothelial cell density of the patients in the combined surgery group are more than in single surgery group. Although it may be more reasonable to compare corneal endothelial cell density before and after surgery, but it is difficult to measure preoperative corneal endothelial cell density because of corneal edema in glaucoma attack. Another factor affecting corneal endothelial cell damage during cataract surgery is the total amount of PE ultrasound used. If the effective PE time is shortened during cataract surgery, the amount of ultrasound energy can be reduced to minimize complications such as corneal edema and corneal endothelial cell loss[28]. Baradarb-Rafii et al[29] reported that total ultrasound use during cataract surgery was significantly associated with loss of corneal endothelial cell. In our study, effective ultrasound time was shorter in the combined surgery group than in the single surgery group, which means that the combined limited PPV is effective for corneal endothelial cell protection. Thus, limited PPV is an effective method to prevent problems occurring in PE alone for AACG. In addition, recent micro-incisional limited PPV may be performed without a conjunctival peritomy and suture. Therefore, even if glaucoma surgery is necessary in the future, preservation of the conjunctiva does not interfere with the success rate of the glaucoma surgery. The disadvantage of this combined surgery is the possibility of retinal tear or retinal detachment due to traction from PPV. However, micro-incisional PPV, which has been widely used recently, has been decreasing the risk because of the increased cutting rate of vitreous cutter. In case of having taken combined, it is recommended to perform fundus examination until the first month after surgery to avoid retinal tears or retinal detachment. There are some reports on partial PPV combined with cataract surgery without any serious complication for malignant glaucoma[30].

The limitations of this study are the follows. First, the number of patients is low. Second, this study is a retrospective study. Third, there can be a possibility of the selection bias. Fourth, preoperative corneal endothelial cell density could not be measured due to corneal edema. There have been many reports on the effects of laser iridotomy and PE in AACG. However, there has been no analysis on the effect of limited PPV combined with PE.

In this study, we compared the single PE, and the combined limited PPV and PE. As a result, there was no significant difference in visual acuity, IOP, anterior chamber depth, and central corneal thickness before and after surgery, but the difference of corneal endothelial cell density measured at 6mo postoperatively was statistically significant. In conclusion, we confirmed that in patients with AACG, performing the micro-incisional single-port sutureless limited PPV followed by PE is more effective than PE alone because of less surgical complications and less corneal endothelial damage.


ACKNOWLEDGEMENTS

Authors’ contributions: All the authors contributed to the conception or design of the work, the acquisition, analysis and interpretation of data, drafting the work, revising it critically for important intellectual content and gave final approval of the version to be published.

Foundation: Supported by Research Fund from Chosun University, 2018.

Conflicts of Interest: Noh HJ, None; Kim ST, None.


REFERENCES

1 Choong YF, Irfan S, Menage MJ. Acute angle closure glaucoma: an evaluation of a protocol for acute treatment. Eye (Lond) 1999;13(Pt 5): 613-616.
https://doi.org/10.1038/eye.1999.168
PMid:10696311

 

2 Alsagoff Z, Aung T, Ang LP, Chew PT. Long-term clinical course of primary angle-closure glaucoma in an Asian population. Ophthalmology 2000;107(12):2300-2304.
https://doi.org/10.1016/S0161-6420(00)00385-7

 

3 Tarongoy P, Ho CL, Walton DS. Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment. Surv Ophthalmol 2009;54(2):211-225.
https://doi.org/10.1016/j.survophthal.2008.12.002
PMid:19298900

 

4 Moghimi S, Hashemian H, Chen R, Johari M, Mohammadi M, Lin SC. Early phacoemulsification in patients with acute primary angle closure. J Curr Ophthalmol 2015;27(3-4):70-75.
https://doi.org/10.1016/j.joco.2015.12.001
PMid:27239581 PMCid:PMC4881187

 

5 Khokhar S, Sindhu N, Pangtey MS. Phacoemulsification in filtered chronic angle closure glaucoma eyes. Clin Exp Ophthalmol 2002;30(4):256-260.
https://doi.org/10.1046/j.1442-9071.2002.00533.x
PMid:12121364

 

6 Consultation section. Cataract surgical problem. J Cataract Refract Surg 2000;26(1):12-20.
https://doi.org/10.1016/S0886-3350(99)00370-3

 

7 Hasegawa Y, Nejima R, Mori Y, Sakisaka T, Minami K, Miyata K, Oshika T. Risk factors for corneal endothelial cell loss by cataract surgery in eyes with pseudoexfoliation syndrome. Clin Ophthalmol 2016;10: 1685-1689.
https://doi.org/10.2147/OPTH.S106661
PMid:27621588 PMCid:PMC5012836

 

8 Lai JS, Tham CC, Chan JC. The clinical outcomes of cataract extraction by phacoemulsification in eyes with primary angle-closure glaucoma (PACG) and co-existing cataract: a prospective case series. J Glaucoma 2006;15(1):47-52.
https://doi.org/10.1097/01.ijg.0000196619.34368.0a
PMid:16378018

 

9 Chang DF. Pars plana vitreous tap for phacoemulsification in the crowded eye. J Cataract Refract Surg 2001;27(12):1911-1914.
https://doi.org/10.1016/S0886-3350(01)00920-8

 

10 Mackool RJ. Pars plana vitreous tap for phacoemulsification in the crowded eye. J Cataract Refract Surg 2002;28(4):572-573.
https://doi.org/10.1016/S0886-3350(02)01312-3

 

11 Dada T, Kumar S, Gadia R, Aggarwal A, Gupta V, Sihota R. Sutureless single-port transconjunctival pars plana limited vitrectomy combined with phacoemulsification for management of phacomorphic glaucoma. J Cataract Refract Surg 2007;33(6):951-954.
https://doi.org/10.1016/j.jcrs.2006.12.037
PMid:17531684

 

12 Miura S, Ieki Y, Ogino K, Tanaka Y. Primary phacoemulsification and aspiration combined with 25-gauge single-port vitrectomy for management of acute angle closure. Eur J Ophthalmol 2008;18(3):450-452.
https://doi.org/10.1177/112067210801800322

 

13 Narayanaswamy A, Baskaran M, Perera SA, Nongpiur ME, Htoon HM, Tun TN, Wong TT, Goh D, Su DH, Chew PT, Ho CL, Aung T. Argon laser peripheral iridoplasty for primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology 2016;123(3):514-521.
https://doi.org/10.1016/j.ophtha.2015.11.002
PMid:26707418

 

14 Aung T, Ang LP, Chan SP, Chew PT. Acute primary angle-closure: long-term intraocular pressure outcome in Asian eyes. Am J Ophthalmol 2001;131(1):7-12.
https://doi.org/10.1016/S0002-9394(00)00621-8

 

15 Husain R, Gazzard G, Aung T, Chen YM, Padmanabhan V, Oen FT, Seah SK, Hoh ST. Initial management of acute primary angle closure: a randomized trial comparing phacoemulsification with laser peripheral iridotomy. Ophthalmology 2012;119(11):2274-2281.
https://doi.org/10.1016/j.ophtha.2012.06.015
PMid:22885123

 

16 Shams PN, Foster PJ. Clinical outcomes after Lensextraction for visually significant cataract in eyes with primary angle closure. J Glaucoma 2012;21(8):545-550.
https://doi.org/10.1097/IJG.0b013e31821db1db
PMid:21623222

 

17 Jacobi PC, Dietlein TS, Lüke C, Engels B, Krieglstein GK. Primary phacoemulsification and intraocular lens implantation for acute angle-closure glaucoma. Ophthalmology 2002;109(9):1597-1603.
https://doi.org/10.1016/S0161-6420(02)01123-5

 

18 Zhang MZ, Lim AS, Yin Wong T. A pilot study of lens extraction in the management of acute primary angle-closure glaucoma. Am J Ophthalmol 2003;135(4):534-536.
https://doi.org/10.1016/S0002-9394(02)02108-6

 

19 Özyol P, Özyol E, Sül S, Baldemir E, Çavdar S. Intra-ocular pressure fluctuation after cataract surgery in primary angle-closure glaucoma eyes medically controlled after laser iridotomy. Acta Ophthalmol 2016;94(7):e528-e533.
https://doi.org/10.1111/aos.13023
PMid:27040022

 

20 Lam DS, Leung DY, Tham CC, Li FC, Kwong YY, Chiu TY, Fan DS. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. Ophthalmology 2008;115(7):1134-1140.
https://doi.org/10.1016/j.ophtha.2007.10.033
PMid:18164064

 

21 Imaizumi M, Takaki Y, Yamashita H. Phacoemulsification and intraocular lens implantation for acute angle closure not treated or previously treated by laser iridotomy. J Cataract Refract Surg 2006;32(1): 85-90.
https://doi.org/10.1016/j.jcrs.2005.11.014
PMid:16516784

 

22 Abell RG, Kerr NM, Howie AR, Mustaffa Kamal MA, Allen PL, Vote BJ. Effect of femtosecond laser-assisted cataract surgery on the corneal endothelium. J Cataract Refract Surg 2014;40(11):1777-1783.
https://doi.org/10.1016/j.jcrs.2014.05.031
PMid:25217072

 

23 Ganekal S, Nagarajappa A. Comparison of morphological and functional endothelial cell changes after cataract surgery: phacoemulsification versus manual small-incision cataract surgery. Middle East Afr J Ophthalmol 2014;21(1):56-60.
https://doi.org/10.4103/0974-9233.124098
PMid:24669147 PMCid:PMC3959043

 

24 Bourne RR, Minassian DC, Dart JK, Rosen P, Kaushal S, Wingate N. Effect of cataract surgery on the corneal endothelium: modern phacoemulsification compared with extracapsular cataract surgery. Ophthalmology 2004;111(4):679-685.
https://doi.org/10.1016/j.ophtha.2003.07.015
PMid:15051198

 

25 Wirbelauer C, Wollensak G, Pham DT. Influence of cataract surgery on corneal endothelial cell density estimation. Cornea 2005;24(2):135-140.
https://doi.org/10.1097/01.ico.0000141234.48967.e3

 

26 Igarashi T, Ohsawa I, Kobayashi M, Igarashi T, Suzuki H, Iketani M, Takahashi H. Hydrogen prevents corneal endothelial damage in phacoemulsification cataract surgery. Sci Rep 2016;6:31190.
https://doi.org/10.1038/srep31190
PMid:27498755 PMCid:PMC4976317

 

27 Lee CH, You IC, Kim YR. Phacoemulsification versus laser peripheral iridotomy in early treatment of acute primary angle-closure glaucoma. J Korean Ophthalmol Soc 2016;57(2):290-295.
https://doi.org/10.3341/jkos.2016.57.2.290

 

28 Kohnen T. Compromised corneal endothelium and cataract: how should we decide? J Cataract Refract Surg 2011;37(8):1377-1378.
https://doi.org/10.1016/j.jcrs.2011.06.013
PMid:21782081

 

29 Baradaran-Rafii A, Rahmati-Kamel M, Eslani M, Kiavash V, Karimian F. Effect of hydrodynamic parameters on corneal endothelial cell loss after phacoemulsification. J Cataract Refract Surg 2009; 35(4):732-737.
https://doi.org/10.1016/j.jcrs.2008.12.017
PMid:19304097

 

30 He F, Qian Z, Lu L, Jiang J, Fan X, Wang Z, Xu X. Clinical efficacy of modified partial pars plana vitrectomy combined with phacoemulsification for malignant glaucoma. Eye (Lond) 2016;30(8):1094-1100.
https://doi.org/10.1038/eye.2016.106
PMid:27229700 PMCid:PMC4985665